Search Our Scientific Publications & Authors

Publications
find publications by category +
Translate page:

A cross sectional analysis from a single institution's experience of psychosocial distress and health-related quality of life in the primary brain tumor population.

Authors:
Dina M Randazzo Frances McSherry James E Herndon Mary Lou Affronti Eric S Lipp Charlene Flahiff Elizabeth Miller Sarah Woodring Maria Freeman Patrick Healy Janet Minchew Susan Boulton Annick Desjardins Gordana Vlahovic Henry S Friedman Stephen Keir Katherine B Peters

J Neurooncol 2017 Sep 1;134(2):363-369. Epub 2017 Jul 1.

Department of Neurology, Duke University Medical Center, Durham, NC, 27710, USA.

Primary brain tumor patients experience high levels of distress. The purpose of this cross-sectional, retrospective study is to evaluate the level and different sources of psychosocial distress and how these pertain to health-related quality of life (HRQoL). The Primary and Recurrent Glioma registry at Duke's The Preston Robert Tisch Brain Tumor Center was queried retrospectively for demographic and clinical information on patients seen between December 2013 and February 2014. Data also included the National Comprehensive Cancer Network's Distress Thermometer (NCCN-DT), Functional Assessment of Cancer Therapy-Brain Cancer (FACT-Br), and Functional Assessment of Chronic Illness Therapy- Fatigue (FACIT-F). 829 subjects completed questionnaires. 54% were male; 96% completed the NCCN-DT; 33.3% had a DT score ≥4 (moderate/severe distress). Women reported DT ≥ 4 more often than men (38.6 vs 29.0%; p = 0.005). Patients within 1 year of diagnosis reported DT ≥ 4 more often than those 1+ years after diagnosis (38.8 vs 30.9%; p = 0.034). 73.0% reported physical problems; the most frequent being fatigue (43.2%) and memory/concentration (40.9%). 42.0% complained of emotional problems with worry (29.4%) and nervousness (22.4%) being the most common. Patients who reported at least one practical, family, emotional or physical problem had significantly lower HRQoL scores (p < 0.001). Primary brain tumor patients experience memory dysfunction, fatigue, nervousness, worry, and financial concerns, which have a negative effect on the patient's HRQoL. By identifying and addressing these stressors, it may be possible to improve patient HRQoL.

Download full-text PDF

 Source
http://dx.doi.org/10.1007/s11060-017-2535-4DOI Listing
September 2017

Publication Analysis

Top Keywords

brain tumor
12
functional assessment
8
health-related quality
8
quality life
8
psychosocial distress
8
reported dt ≥ 4
8
primary brain
8
distress
5
54% male
4
male 96%
4
96% completed
4
completed nccn-dt
4
questionnaires 54%
4
829 subjects
4
subjects completed
4
completed questionnaires
4
nccn-dt 333%
4
score ≥4
4
women reported
4
february 2014
4

Keyword Occurance

Similar Publications

The 2016 Edition of the WHO Classification of Primary Brain Tumors: Applicable to Assess Individual Risk of Recurrence in Atypical Meningioma? A Single-Center Experience.

Authors:
Meike Unteroberdörster Anna Michel Marvin Darkwah Oppong Ramazan Jabbarli Nicolai El Hindy Karsten H Wrede Ulrich Sure Daniela Pierscianek

J Neurol Surg A Cent Eur Neurosurg 2021 Apr 12. Epub 2021 Apr 12.

Department of Neurosurgery, University Hospital of Essen, Essen, Germany.

Background And Study Aims/object:  Despite the relevance of molecular criteria for brain tumor diagnosis and prognosis, meningioma grading is still solely based on histologic features. Atypical meningiomas (AMs; WHO grade II) display a great histologic heterogeneity and individual courses of disease can differ significantly. This study aimed to identify clinically aggressive AMs that are prone to early recurrence after gross total resection (GTR) by assessing a specific histologic score. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

The Influence of Music on Neurosurgical Cases: A Neglected Knowledge.

Authors:
Elena Romana Gasenzer Ayhan Kanat Makoto Nakamura

J Neurol Surg A Cent Eur Neurosurg 2021 Apr 12. Epub 2021 Apr 12.

Division of Neurosurgery, Department of Clinical Medicine, University Witten/Herdecke, Witten, Nordrhein-Westfalen, Germany.

Background:  The human brain can respond to and participate in music. Learning to play a musical instrument requires complex multimodal skills involving the simultaneous perception of several sensory modalities. In case of brain damage, the musician and nonmusician brains may have different capacities for reorganization and neural remapping. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

An update on the role of miR-379 in human disorders.

Authors:
Soudeh Ghafouri-Fard Donya Shaterabadi Afete Abak Hamed Shoorei Zahra Bahroudi Mohammad Taheri Seyed Ali Mousavinejad

Biomed Pharmacother 2021 Apr 9;139:111553. Epub 2021 Apr 9.

Skull Base Research Center, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address:

miR-379 is a miRNA transcribed from the MIR379 locus on 14q32.31. This miRNA is located in an evolutionarily conserved miRNA cluster in an imprinted region that contains DLK1 and DIO3 genes. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

Our reference: BBR 113290 Article reference: BBR_BBRES-D-20-01218 Article title: Apelin-13 activates the hippocampal BDNF/TrkB signaling pathway and suppresses neuroinflammation in male rats with cisplatin-induced cognitive dysfunction To be published in: Behavioural Brain Research.

Authors:
Sinan Saral Atilla Topçu Mehmet Alkanat Tolga Mercantepe Kerimali Akyıldız Lamiye Yıldız Levent Tümkaya Zihni Açar Yazıcı Adnan Yılmaz

Behav Brain Res 2021 Apr 9:113290. Epub 2021 Apr 9.

Recep Tayyip Erdogan University, Faculty of Medicine, Department of Biochemistry, Rize, Turkey. Electronic address:

It has been established that cisplatin causes neuronal damage and cognitive impairment. However, the mechanism is not sufficiently clear. Apelin-13 is an endogenous peptide with strong neuroprotective effects through the synthesis of neurotrophic factors and suppression of inflammation. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

The long noncoding RNA lnc-HLX-2-7 is oncogenic in Group 3 medulloblastomas.

Authors:
Keisuke Katsushima Bongyong Lee Haritha Kunhiraman Cuncong Zhong Rabi Murad Jun Yin Ben Liu Alexandra Garancher Ignacio Gonzalez-Gomez Hector L Monforte Stacie Stapleton Rajeev Vibhakar Chetan Bettegowda Robert J Wechsler-Reya George Jallo Eric Raabe Charles G Eberhart Ranjan J Perera

Neuro Oncol 2021 Apr;23(4):572-585

Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, School of Medicine, Johns Hopkins University, Baltimore, Maryland.

Background: Medulloblastoma (MB) is an aggressive brain tumor that predominantly affects children. Recent high-throughput sequencing studies suggest that the noncoding RNA genome, in particular long noncoding RNAs (lncRNAs), contributes to MB subgrouping. Here we report the identification of a novel lncRNA, lnc-HLX-2-7, as a potential molecular marker and therapeutic target in Group 3 MBs. Read More

View Article and Full-Text PDF
April 2021
Similar Publications